Ranbaxy Laboratories is in speaks with Ind-Swift Labs

Indian medicine manufacturer Ranbaxy Laboratories is in speaks with Ind-Swift Labs to source ingredient to produce a generic version of Pfizer Inc.’s (PFE) Lipitor blood cholesterol medicine.

Ind-Swift vice chairman N. R. Munjal stated that the firm is talking about various choices to deliver intermediate or final active pharmaceutical raw materials atorvastatin to Ranbaxy.

Ranbaxy plans to release the cholesterol medicine in the United states. at the end of November, but regulatory and producing issues at the Indian firm have late FDA authorization for the medicine.

Be Sociable, Share!
Tags: ,

Stock Market Basics For Beginners

What are Premium Issues?

What are Premium Issues? Most Companies shares have a face value of Rs.10 though not always offer to the public at this price. Companies can offer a stock (share) ...…

Stock trading rules

Stock trading rules Set your goal and work out a budget for how much amount you want to invest in market. Avoid reacting to short-term pressure and expect a ...…

Bad Delivery

Bad Delivery Designation implying that a security doesn't fulfill all of the needs or have all the required endorsements to permit the certificate to be transferred to ...…

What Is a Discount Price?

What Is a Discount Price? Securities are usually released in denominations of Rs 15, 30 or 200. This is called as a Face Value and when it is sold below ...…

Stock Splits

Stock Splits [ad name="468x15- 5 link"] what is a stock split? A stock split is really a procedure helpful to enhance the number of stocks in order to issue ...…

Indian Share Tips

NSE Investment Site

Market Update

Share Guide

Designed by VMV
web
analytics